FindTrial
Sign In

A study to assess the expression of three tumor markers E-Cadherin, Vimentin and CD44 in malignant epithelial ovarian tumors

Expression of E-Cadherin, Vimentin and CD44 in malignant epithelial ovarian tumors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2019/08/020953
Enrollment
25
Registered
2019-08-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C569- Malignant neoplasm of unspecifiedovary

Interventions

None listed

Sponsors

Maulana Azad Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients above eighteen years diagnosed with malignant epithelial ovarian tumors

Exclusion criteria

Exclusion criteria: Patients with a history of radiotherapy or chemotherapy will be excluded from the study

Design outcomes

Primary

MeasureTime frame
Expression of E-cadherin, Vimentin and CD44 in malignant epithelial ovarian tumorsTimepoint: 1 year—

Secondary

MeasureTime frame
Correlation of expression of E-cadherin, Vimentin and CD44 with clinicopathological parametersTimepoint: 1 year—

Countries

India

Contacts

Public ContactShramana Mandal

Maulana Azad Medical College

shra_mana@hotmail.com9811686401

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026